Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,020 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

NCT05597085

Conditions
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • Fortis Memorial Research Institute Gurugram, Haryana, India
  • Malabar Cancer Center Thalassery, Kerala, India
  • Rajiv Gandhi Cancer Institute and Research Centre New Delhi, National Capital Territory of Delhi, India
  • Indo-American Cancer & Research Centre Hyderabad, Telangana, India
View Trial Details
Completed

A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

NCT01855750

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tucson, Arizona, United States
  • Greenbrae, California, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 201 locations
View Trial Details
Completed

A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma

NCT03357952

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • Algemeen Ziekenhuis Klina Brasschaat, Belgium
  • AZ St.-Jan Brugge-Oostende AV Bruges, Belgium
  • UZBrussel Brussels, Belgium
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

NCT01703481

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +29 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 37 locations
View Trial Details
Completed

A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation

NCT02918331

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hiroshima, Japan
  • Kanazawa, Japan
  • Nagoya, Japan
  • Osaka, Japan
View Trial Details
Completed

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

NCT03768960

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Avron Hospitals Pvt. Ltd Ahmedabad, India
  • M S Ramaiah Medical College and Hospital Bengaluru, India
  • Apollo Hospitals Bhubaneswar, India
  • Sparsh Hospitals & Critical Care (Pvt) Ltd Bhubaneswar, India
View all 16 locations
View Trial Details
Completed

Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

NCT03476655

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Apollo Hospitals International Limited Ahmedabad, India
  • Healthcare Global (HCG) Hospital Bangalore, India
  • Fortis Memorial Research Institute Gurgaon, India
  • Basavatarakam Indo-American Hospital Hyderabad, India
View Trial Details

Related conditions